Abbvie Inc
NYSE:ABBV
Abbvie Inc
NYSE:ABBV
Price:
167.8 USD
-1.03%
Market Closed
Updated:
Apr 25, 2024
Abbvie Inc
Total Liabilities
Last
Value
3-Years CAGR
5-Years CAGR
|
Abbvie Inc
Total Liabilities Peer Comparison
Comparables:
GILD
AMGN
VRTX
REGN
SGEN
Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abbvie Inc
NYSE:ABBV
|
Total Liabilities
$124.4B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
13%
|
CAGR 10-Years
18%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Liabilities
$39.3B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
13%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Liabilities
$90.9B
|
CAGR 3-Years
19%
|
CAGR 5-Years
11%
|
CAGR 10-Years
8%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Liabilities
$5.1B
|
CAGR 3-Years
19%
|
CAGR 5-Years
23%
|
CAGR 10-Years
18%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Liabilities
$7.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
19%
|
CAGR 10-Years
22%
|
|
|
Seagen Inc
NASDAQ:SGEN
|
Total Liabilities
$1.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
40%
|
CAGR 10-Years
16%
|
See Also
What is Abbvie Inc's Total Liabilities?
Total Liabilities
124.4B
USD
124.4B
USD
Based on the financial report for Dec 31, 2023, Abbvie Inc's Total Liabilities amounts to 124.4B USD.
What is Abbvie Inc's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
18%
18%
Over the last year, the Total Liabilities growth was 2%. The average annual Total Liabilities growth rates for Abbvie Inc have been -3% over the past three years , 13% over the past five years , and 18% over the past ten years .
You don't have any saved screeners yet
